- Home
- TULP vs BIVI Comparison
TULP vs BIVI Comparison
Compare TULP & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.93
HOLD
Current Price
$1.46
Company Overview
Basic Information| Metric | TULP | BIVI |
|---|---|---|
| Founded | 1990 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 8.5M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | TULP | BIVI |
|---|---|---|
| Price | $3.93 | $1.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.1K | ★ 56.8K |
| Earning Date | 02-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.48 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.63 | $0.75 |
| 52 Week High | $4.79 | $9.09 |
Technical Indicators
Market Signals| Indicator | TULP | BIVI |
|---|---|---|
| Relative Strength Index (RSI) | 39.02 | 55.79 |
| Support Level | $3.68 | $1.42 |
| Resistance Level | $4.10 | $1.52 |
| Average True Range (ATR) | 0.08 | 0.08 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 22.22 | 71.43 |
Price Performance
Historical Comparison TULP
BIVI
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.